O'Brien S - Search Results

1

Use of denaturing HPLC for detection of mutations in the BCR-ABL kinase domain in patients resistant to Imatinib.

Irving JA, O'Brien S, Lennard AL, Minto L, Lin F, Hall AG. Irving JA, et al. Clin Chem. 2004 Jul;50(7):1233-7. doi: 10.1373/clinchem.2004.034801. Clin Chem. 2004. PMID: 15229152 No abstract available.

2

Molecular monitoring in chronic myeloid leukemia patients who achieve complete cytogenetic remission on imatinib.

Lin F, Drummond M, O'Brien S, Cervantes F, Goldman J, Kaeda J. Lin F, et al. Blood. 2003 Aug 1;102(3):1143. doi: 10.1182/blood-2002-12-3916. Blood. 2003. PMID: 12869491 Free article. No abstract available.

3

Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfa.

Marin D, Marktel S, Bua M, Szydlo RM, Franceschino A, Nathan I, Foot N, Crawley C, Na Nakorn T, Olavarria E, Lennard A, Neylon A, O'Brien SG, Goldman JM, Apperley JF. Marin D, et al. Leukemia. 2003 Aug;17(8):1448-53. doi: 10.1038/sj.leu.2402996. Leukemia. 2003. PMID: 12886230

4

A single nucleotide polymorphism in the coding region of ABL and its effects on sensitivity to imatinib.

Crossman LC, O'Hare T, Lange T, Willis SG, Stoffregen EP, Corbin AS, O'Brien SG, Heinrich MC, Druker BJ, Middleton PG, Deininger MW. Crossman LC, et al. Leukemia. 2005 Nov;19(11):1859-62. doi: 10.1038/sj.leu.2403935. Leukemia. 2005. PMID: 16151465

5

Clinical results with imatinib in chronic myeloid leukaemia.

Crossman LC, O'Brien S. Crossman LC, et al. Leuk Res. 2004 May;28 Suppl 1:S3-9. doi: 10.1016/j.leukres.2003.10.024. Leuk Res. 2004. PMID: 15036936 Review.

6

An update on chronic myeloid leukaemia.

Stark G, O'Brien SG. Stark G, et al. Clin Med (Lond). 2001 Sep-Oct;1(5):354-7. doi: 10.7861/clinmedicine.1-5-354. Clin Med (Lond). 2001. PMID: 11706876 Free PMC article.

7

Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia.

O'Brien SG, Meinhardt P, Bond E, Beck J, Peng B, Dutreix C, Mehring G, Milosavljev S, Huber C, Capdeville R, Fischer T. O'Brien SG, et al. Br J Cancer. 2003 Nov 17;89(10):1855-9. doi: 10.1038/sj.bjc.6601152. Br J Cancer. 2003. PMID: 14612892 Free PMC article. Clinical Trial.

8

Antisense BCR-ABL oligomers cause non-specific inhibition of chronic myeloid leukemia cell lines.

O'Brien SG, Kirkland MA, Melo JV, Rao MH, Davidson RJ, McDonald C, Goldman JM. O'Brien SG, et al. Leukemia. 1994 Dec;8(12):2156-62. Leukemia. 1994. PMID: 7808004

9

The UK SPIRIT 1 trial in newly diagnosed chronic myeloid leukaemia.

Gallipoli P, Clark RE, Byrne J, Apperley JF, Milojkovic D, Foroni L, Goldman JM, O'Brien S. Gallipoli P, et al. Br J Haematol. 2022 Mar;196(6):e55-e57. doi: 10.1111/bjh.17961. Epub 2022 Jan 6. Br J Haematol. 2022. PMID: 34993961 Free PMC article. No abstract available.

10

Extramedullary blast crises in CML patients in complete hematological remission treated with imatinib mesylate.

Simpson E, O'Brien SG, Reilly JT. Simpson E, et al. Clin Lab Haematol. 2006 Jun;28(3):215-6. doi: 10.1111/j.1365-2257.2006.00782.x. Clin Lab Haematol. 2006. PMID: 16706941 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,119 results

Search Page

Filters